0.3300
0.0000
(0.00%)
At close: January 10 at 4:27:05 PM GMT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
3/31/2020
Operating Cash Flow
-2,284.0000
-2,284.0000
-4,064.0000
-2,375.0000
-82.7120
Investing Cash Flow
-122.0000
-122.0000
-2,028.0000
-418.0000
-160.7910
Financing Cash Flow
3,042.0000
3,042.0000
-365.0000
9,115.0000
-190.5080
End Cash Position
870.0000
870.0000
234.0000
6,691.0000
293.1480
Capital Expenditure
-122.0000
-122.0000
-2,028.0000
-418.0000
-160.8280
Issuance of Capital Stock
3,911.0000
3,911.0000
5.0000
9,582.0000
--
Repayment of Debt
-22.0000
-22.0000
-37.0000
--
--
Free Cash Flow
-2,406.0000
-2,406.0000
-6,092.0000
-2,793.0000
-243.5400
3/31/2020 - 12/22/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALT1.MX Altimmune, Inc.
148.05
0.00%
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
3G0.F Altimmune, Inc.
6.73
-5.92%
7IZ.MU Ziccum AB
0.0298
-29.72%
ORN.F Oryzon Genomics S.A.
1.5020
+2.18%
41X.F Ardelyx, Inc.
5.12
+0.16%
4AJ0.SG Alk-Abello A/S
19.46
+0.46%
CXF.F Chimerix, Inc.
3.1350
-6.00%
BLE.BE bluebird bio Inc
0.3708
-3.01%